May 16, 2023
University of Virginia biology professor George Bloom is receiving revived interest lately in an old paper. Eleven years ago, he was part of a research team that illuminated the Alzheimer’s brain target that a new and exciting – but not yet approved – drug called Donanemab now acts upon.
Click here, to read full story.
Photo credit: George Bloom is a biologist and UVA Health researcher who has studied the target Donanemab acts upon. (UVA Health photo)